Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 1317-26-6
2. Aluminum Hydroxide/magnesium Hydroxide
3. Aluminum Hydroxide/magnesium Hydroxide - Magaldrate C410
4. Aluminum Hydroxide/magnesium Hydroxide - Magaldrate C632
Molecular Weight | 86.310 g/mol |
---|---|
Molecular Formula | AlH3MgO2- |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 0 |
Exact Mass | 85.9798844 g/mol |
Monoisotopic Mass | 85.9798844 g/mol |
Topological Polar Surface Area | 2 Ų |
Heavy Atom Count | 4 |
Formal Charge | -1 |
Complexity | 0 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 4 |
A02AD02
S76 | LUXPHARMA | Pharmaceuticals Marketed in Luxembourg | Pharmaceuticals marketed in Luxembourg, as published by d'Gesondheetskeess (CNS, la caisse nationale de sante, www.cns.lu), mapped by name to structures using CompTox by R. Singh et al. (in prep.). List downloaded from https://cns.public.lu/en/legislations/textes-coordonnes/liste-med-comm.html. Dataset DOI:10.5281/zenodo.4587355
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
27
PharmaCompass offers a list of Magaldrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Magaldrate manufacturer or Magaldrate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Magaldrate manufacturer or Magaldrate supplier.
PharmaCompass also assists you with knowing the Magaldrate API Price utilized in the formulation of products. Magaldrate API Price is not always fixed or binding as the Magaldrate Price is obtained through a variety of data sources. The Magaldrate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Glysan manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Glysan, including repackagers and relabelers. The FDA regulates Glysan manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Glysan API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Glysan manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Glysan supplier is an individual or a company that provides Glysan active pharmaceutical ingredient (API) or Glysan finished formulations upon request. The Glysan suppliers may include Glysan API manufacturers, exporters, distributors and traders.
click here to find a list of Glysan suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Glysan DMF (Drug Master File) is a document detailing the whole manufacturing process of Glysan active pharmaceutical ingredient (API) in detail. Different forms of Glysan DMFs exist exist since differing nations have different regulations, such as Glysan USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Glysan DMF submitted to regulatory agencies in the US is known as a USDMF. Glysan USDMF includes data on Glysan's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Glysan USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Glysan suppliers with USDMF on PharmaCompass.
A Glysan written confirmation (Glysan WC) is an official document issued by a regulatory agency to a Glysan manufacturer, verifying that the manufacturing facility of a Glysan active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Glysan APIs or Glysan finished pharmaceutical products to another nation, regulatory agencies frequently require a Glysan WC (written confirmation) as part of the regulatory process.
click here to find a list of Glysan suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Glysan as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Glysan API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Glysan as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Glysan and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Glysan NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Glysan suppliers with NDC on PharmaCompass.
Glysan Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Glysan GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Glysan GMP manufacturer or Glysan GMP API supplier for your needs.
A Glysan CoA (Certificate of Analysis) is a formal document that attests to Glysan's compliance with Glysan specifications and serves as a tool for batch-level quality control.
Glysan CoA mostly includes findings from lab analyses of a specific batch. For each Glysan CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Glysan may be tested according to a variety of international standards, such as European Pharmacopoeia (Glysan EP), Glysan JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Glysan USP).